Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 443

The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.

Calcium-Antagonist Drugs

Abernethy, Darrell R., Schwartz, Janice B.·1999·New England Journal of Medicine

Abstract

Drugs classified as calcium antagonists or calcium-channel blockers were introduced into clinical medicine in the 1960s and are now among the most frequently prescribed drugs for the treatment of cardiovascular diseases.1 Although the currently available calcium antagonists are chemically diverse, they share the common property of blocking the transmembrane flow of calcium ions through voltage-gated L-type (slowly inactivating) channels.2 These drugs have proved effective in patients with hypertension, angina pectoris, and cardiac arrhythmias and may be beneficial in patients with left ventricular diastolic dysfunction, Raynaud's phenomenon, migraine, preterm labor, esophageal spasm, and bipolar disorders.L-Type Calcium ChannelsAll calcium antagonists . . .

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejm199911043411907

Cites

76 of 76 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 76 references

Cited by

See all 443

Metadata

Authors
Abernethy, D. R., & Schwartz, J. B.
Venue
New England Journal of Medicine
Published
1999-11-04
Volume
341
Issue
19
Pages
1447-1457
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2324185390
Cited by
443
References
76
FWCI
6.20
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Calcium-Antagonist Drugs. https://app.cochat.ai/papers/10.1056/nejm199911043411907
The paper
Abernethy, D. R., & Schwartz, J. B. (1999). Calcium-Antagonist Drugs. New England Journal of Medicine. https://doi.org/10.1056/nejm199911043411907

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.